- AutorIn
- Susanne Kuhnt
- Elmar Brähler
- Hermann Faller
- Martin Härter
- Monika Keller
- Holger Schulz
- Karl Wegscheider
- Joachim Weis
- Anna Boehncke
- Bianca Hund
- Katrin Reuter
- Matthias Richard
- Susanne Sehner
- Hans-Ulrich Wittchen
- Uwe Koch
- Anja Mehnert
- Titel
- Twelve-Month and Lifetime Prevalence of Mental Disorders in Cancer Patients
- Zitierfähige Url:
- https://nbn-resolving.org/urn:nbn:de:bsz:14-qucosa2-706011
- Quellenangabe
- Psychotherapy and psychosomatics Erscheinungsort: Basel
Verlag: Karger
Erscheinungsjahr: 2016
Jahrgang: 85
Heft: 5
Seiten: 289-296
ISSN: 0365-5822
E-ISSN: 1423-0348 - Erstveröffentlichung
- 2016
- Abstract (EN)
- Background: Psychological problems are common in cancer patients. For the purpose of planning psycho-oncological interventions and services tailored to the specific needs of different cancer patient populations, it is necessary to know to what extent psychological problems meet the criteria of mental disorders. The purpose of this study was to estimate the 12-month and lifetime prevalence rates of mental disorders in cancer patients. Methods: A representative sample of patients with different tumour entities and tumour stages (n = 2,141) in outpatient, inpatient and rehabilitation settings underwent the standardized computer-assisted Composite International Diagnostic Interview for mental disorders adapted for cancer patients (CIDI-O). Results: The overall 12-month prevalence for any mental disorder was 39.4% (95% CI: 37.3–41.5), that for anxiety disorders was 15.8% (95% CI: 14.4–17.4), 12.5% (95% CI: 11.3–14.0) for mood disorders, 9.5% (95% CI: 8.3–10.9) for somatoform disorders, 7.3% (95% CI: 6.2–8.5) for nicotine dependence, 3.7% (95% CI: 3.0–4.6) for disorders due to general medical condition, and 1.1% (95% CI: 0.7–1.6) for alcohol abuse or dependence. Lifetime prevalence for any mental disorder was 56.3% (95% CI 54.1–58.6), that for anxiety disorders was 24.1% (95% CI: 22.3–25.9), 20.5% (95% CI: 18.9–22.3) for mood disorders, 19.9% (95% CI: 18.3–21.7) for somatoform disorders, 18.2% (95% CI: 16.6–20.0) for nicotine dependence, 6.4% (95% CI: 5.4–7.6) for alcohol abuse or dependence, 4.6% (95% CI: 3.8–5.6) for disorders due to general medical condition, and 0.2% (95% CI: 0.1–0.6) for eating disorders. Conclusions: Mental disorders are highly prevalent in cancer patients, indicating the need for provision of continuous psycho-oncological support from inpatient to outpatient care, leading to an appropriate allocation of direct personnel and other resources.
- Andere Ausgabe
- Link zum Artikel der zuerst in der Zeitschrift 'Psychotherapy and psychosomatics' erschienen ist
DOI: 10.1159/000446991 - Freie Schlagwörter (DE)
- Psychische Störungen, Krebspatienten, psychoonkologische Interventionen
- Freie Schlagwörter (EN)
- Mental disorders, Cancer patients, Psycho-oncological interventions
- Klassifikation (DDC)
- 610
- Verlag
- Karger, Basel
- Förder- / Projektangaben
- German Cancer Aid Psychosocial oncology funding priority program ID: 107465
- Version / Begutachtungsstatus
- publizierte Version / Verlagsversion
- URN Qucosa
- urn:nbn:de:bsz:14-qucosa2-706011
- Veröffentlichungsdatum Qucosa
- 22.05.2020
- Dokumenttyp
- Artikel
- Sprache des Dokumentes
- Englisch
- Lizenz / Rechtehinweis